Carterra 23/09/25
LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Drug Discovery 2025, ELRIG – 04.07.2025
DDL 2025
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
HCMed

FGK celebrates its 15th anniversary

Dedicated to clinical research since 2002
FGK Clinical Research GmbH, a Europe based CRO, was registered in August 2002 in Munich, Germany. In 2017, Managing Directors Edgar Fenzl and Martin Krauss are excited to announce its 15th anniversary:
“FGK started out with 4 employees in 2002. We are proud to say that FGK has grown to a CRO with more than 100 employees now, being able to manage all kinds of trials not only in Europe, but worldwide. At the same time, many of our employees have been with us for a long part of this journey. That is what we value most in our team: The expert knowledge base, familiarity and trust that arises through a long term partnership and which we pass on to our clients as well“, says Edgar Fenzl, Managing Director.
Over the years FGK has successfully expanded to Prague, London, Budapest and Warsaw. In addition, the affiliates “FGK Representative Service” and “FGK Pharmacovigilance” were founded in order to provide some special services to FGK’s customers. Many clients are Biotech and Medical Device companies who value the personal contact and individual solutions FGK can provide based upon its size and owner structure.
Managing Director Martin Krauss says: “A high degree of FGK’s success is owned to our clients, our cooperating partners and our excellent team of staff members; therefore we would like to thank those who have chosen to collaborate with us. The field of Clinical Research is changing fast and thus we are very grateful for having been part of the development of new therapies for such a long time now. Responding to the individual challenges each project entails and satisfying previously unmet needs motivates us every day. We look forward to continuing FGK’s success story in the future!”
YPSOMED website ad
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Nipro – 09.06.2025
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025